GRI

Winter plan: point of situation on the supply of certain major winter drugs

News Healthcare & Pharma Law & Policy Updates
Date: 24th Mar, 2025 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

On 24/03/2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding "Winter plan: point of situation on the supply of certain major winter drugs". The distribution of amoxicillin/clavulanic acid to pharmacies will be managed by wholesalers/grossists at a level of 120% of their monthly needs, while certain measures implemented for the winter season will be eased due to improved availability of medications.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Federal Government regulates criteria for recognition of high performance entities and athletes in sports shooting
Date: 11th Apr, 2025 Source: Ministry of Justice and Public Security (MJSP) Country: Brazil
News Consumer protection Law & Policy Updates
The BCRA and the PBOC renew the activated SWAP section
Date: 10th Apr, 2025 Source: Central Bank of the Argentine Republic Country: Argentina
News Financial services Law & Policy Updates
Date: 9th Apr, 2025 Source: Federal Public Ministry (Ministério Público Federal – MPF) Country: Brazil
News Anti-bribery and corruption Law & Policy Updates

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales